Ep 20. Re-released Full Length: Group B Streptococcus (GBS) Part 2: What is the evidence for screening all pregnant women with a swab?
Cocooned HealthShow Notes
Part 2: Group B Streptococcus (GBS) What is the evidence for screening all pregnant women with a swab? One doctor would get the swab on the private system in the UK and another would not Listen Now. (June's Episode Re-released: Apologies we had a technical issue with this episode where it was unintentionally shortened in some apps - now resolved) Dr Lydia Yarlott and Dr Eliz Kilich discuss the two sides of the coin: To get the screening swab for Group B Streptococcus (GBS) or not. The discussion revolves around why different countries have different policies. GBS is a bacteria carries by around 1 in 4 people and can cause sepsis, pneumonia and meningitis in babies when a mother who carries the bacteria (as part of her normal microflora) inadvertently transfers it to baby during delivery of her baby. It is however rare. We follow up on the previous episode with Professor Kirsty Le Doare, an expert in GBS and a leader in running the trials that will hopefully lead to a GBS vaccine for the public in the future. Thus the discussion follows: 1. What are the benefits of the swab as part of screening and if your country of residence does not offer it as routine, would the hosts consider getting it. Spoiler - one would, one wouldn't 2. What are the risk of the bacteria to the baby and what is the actual numerical risk. How many babies need to be delivered to a mum who carries the bacteria for one of the babies to actually get the disease? 3. Are there any downsides to the antibiotics in labour for GBS given that there will be some people due to screening who get it that may not have needed it? If so is there actual proof? How to we weigh this up against the risk of severe illness to baby? 4. What was the evidence that led to some of the differing recommendations and why can't we do a study now.
References:
Azad, M. B. et al. Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study. BJOG 123: 983-993. (2015) Corvaglia. et al. Influence of intrapartum antibiotic prophylaxis for Group B Streptococcus on gut microbiota in the first month of life. JPGN 62: 304-308. (2016) Gensollen, et al. How colonization by microbiota in early life shapes the immune system. Science 352(6285): 539-543. (2016) Group B Streptococcus Incidence. Rates of GBS infection in Babies. Group B Strep Support Charity: https://gbss.org.uk/professional-resources/gbs-incidence/ Accessed June 2025 Le Doare, K. et al. Intrapartum antibiotic chemoprophylaxis policies for prevention of Group B Streptococcal disease worldwide: Systematic Review. Clin Infect Dis 65(S2): S143-S151. (2017) Matorras et al. Maternal colonization by group B streptococci and puerperal infection; analysis of intrapartum chemoprophylaxis. Eur J Obstet Gynecol Reprod Biol 38(3): 203-207. (1991) Mazzola et al. Early gut microbiota perturbations following intrapartum antibiotic prophylaxis to prevent group B streptococcal disease. PLoS ONE 11(6): e015727. (2016) Nanduri et al. Epidemiology of invasive early-onset and late-onset group B streptococcal disease in the United States, 2006 to 2015: Multistate laboratory and population-based surveillance. JAMA Pediatr 173(3): 224-233. (2019) Ohlsson, A et al. Intrapartum antibiotics for known maternal group B streptococcal colonization. Cochrane Database Syst Rev 1: CD007467. (2013) Puopolo, K. M. et al. American Academy of Pediatrics, Committee on Fetus and Newborn, Committee on Infectious Diseases et al. Management of infants at risk for Group B Streptococcal disease. Pediatrics 144 (2): e20191881. (2019) Van Dyke, M. K. et al. Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med 360(25): 2626-2636. (2009)Whilst no information is perfect, it changes, we have done our best to bring together information to the best of our knowledge. It is always important to discuss anything we talk about with your own healthcare p
More from Cocooned Health
Ep 38. Heatwaves in pregnancy debunked. Expert Guest: Dr Darshnika LakhooToday we explore what it means to be in a heatwave and pregnant. It can get uncomfortable but what is the current latest understanding. How important is it really to cool down, or is it all just unknown? We explore this in our latest episode with Dr Darshnika Lakhoo. Darshnika Lakhoo is a medical doctor with a master’s in public health, serving as a research clinician at Wits Planetary Health Research, in Johannesburg. Her work is centered on understanding and mitigating the impacts of heat on maternal and child health.
Ep 37. Heatwaves and Newborns Heat, Pregnancy and Preterm Birth: What Does the Evidence Really Tell Us? Pregnancy during a heatwave can be uncomfortable enough but should pregnant people or parents actually be worried about the heat? There is an immune theory regarding this process and given higher temperatures can mimic infection we delve into this area as a call from parents. In this episode, we discuss mostly the impact on newborn health. We also briefly touch on the research including the Nature Medicine systematic review and meta-analysis examining how heat exposure affects pregnancy health. Bringing together 198 studies from 66 countries the research provides one of the most comprehensive assessments yet of pregnancy and extreme heat. In September's 2026 episodes we speak to one of the researchers behind this study directly - so stay tuned We unpack what scientists actually mean by a heatwave and why there is no single temperature that defines one. We explore whether it is absolute heat or unusually hot weather for a particular location that matters most, and what the findings mean for pregnant women living in temperate countries such as the UK. We explore practical advice for parents for newborns including 1) what to wear 2) strategies in limited environments 3) why the car can be super dangerous 4) why children are more vulnerable A conversation about climate, pregnancy and risk and about communicating emerging evidence in a way that helps pregnant women stay informed without making hot weather another source of anxiety.
Ep 36. A new meningitis vaccine for teenagers? A short recap ... A short recap of episode 30: Why the meningitis vaccine is being introduced and why it wasn't previously offered. What strains it covers and what it does not. In this episode of Cocooned Health, we’re joined by Dr Eliza Gil, Academic Clinical Lecturer in Infection at the London School of Hygiene and Tropical Medicine and Honorary Clinical Microbiologist at Great Ormond Street Hospital. She breaks down this fascinating topic. Listen to episode 30 for the full episode
Ep 35. The Midwife Series Episode 4: Analysis - How 100 Midwives Generated A Solution To Vaccine Conversations In Pregnancy - “Sometimes It’s The Simplest Thing.” Part of the 4 part series: The Midwife Series Episode 1: Frontline Insights - Midwives On Vaccine Conversations In Pregnancy. "It's Our Role To Guide And Support" The Midwife Series Episode 2: Emergence Of An Idea: What Do Midwives Need And Why? “The Easier It Is To Access, The More Utilised It Will Be” The Midwife Series Episode 3: Honing And Developing - The Checklist That Could Transform Vaccine Conversations. The Midwife Series Episode 4: Analysis - How 100 Midwives Generated A Solution To Vaccine Conversations In Pregnancy - “Sometimes It’s The Simplest Thing” In the fourth and final episode of our special Midwife Series, Cocooned Health co-hosts Dr Eliz Kilich and Dr Lydia Yarlott review the results of a survey with over 100 participants. 120 participants started the survey, with 102 participants completing all questions. The survey was conducted using Qualtrics XM with 37 questions. The questions included demographics, communication and confidence, innovative strategies, knowledge base and questions about the Cocooned Health podcast. During this episode co-hosts discuss each question one by one, excluding the podcast questions. They provide insights and analysis of the answers. They give their opinions about how this relates to the podcast groups conducted. It is from here they discuss the future innovative strategies that could be developed. This episode series was developed with funding support from Pfizer Ltd. Pfizer Ltd had no involvement in the content, production, review, analysis, or editorial decisions relating to this series. Funding was provided through an independent grant to support Cocooned Health's work. All views and content are those of the contributors and Cocooned Health. All other Cocooned Health podcast content is produced independently. The views expressed by participants are their own and do not necessarily reflect those of their institutions, employers, or affiliated organisations. This podcast is intended for educational purposes only and should not replace advice from your own healthcare professional regarding individual medical care. Midwives were remunerated for their time. DM us at cocoonedhealthpodcast or email: [email protected]
Ep 34. The Midwife Series Episode 3: Honing And Developing – The Checklist That Could Transform Vaccine Conversations. Part of the 4 part series: The Midwife Series Episode 1: Frontline Insights - Midwives On Vaccine Conversations In Pregnancy. "It's Our Role To Guide And Support" The Midwife Series Episode 2: Emergence Of An Idea: What Do Midwives Need And Why? “The Easier It Is To Access, The More Utilised It Will Be” The Midwife Series Episode 3: Honing And Developing - The Checklist That Could Transform Vaccine Conversations. The Midwife Series Episode 4: Analysis - How 100 Midwives Generated A Solution To Vaccine Conversations In Pregnancy - “Sometimes It’s The Simplest Thing” In the third episode of our special Midwife Series, Cocooned Health co-hosts Dr Eliz Kilich and Dr Lydia Yarlott are joined by three experienced midwives to further develop the most desired intervention by midwives from our conducted survey of over 100 midwife participants. They build of the previous 2 other podcast conversation refining what is needed. By exploring the nuance of conversations, what is expected of midwives and the limitations we role play the use of the intervention and discuss how this influences midwife confidence. This episode series was developed with funding support from Pfizer Ltd. Pfizer Ltd had no involvement in the content, production, review, analysis, or editorial decisions relating to this series. Funding was provided through an independent grant to support Cocooned Health's work. All views and content are those of the contributors and Cocooned Health. All other Cocooned Health podcast content is produced independently. The views expressed by participants are their own and do not necessarily reflect those of their institutions, employers, or affiliated organisations. This podcast is intended for educational purposes only and should not replace advice from your own healthcare professional regarding individual medical care. Midwives were remunerated for their time. DM us at cocoonedhealthpodcast or email: [email protected] episode has undergone additional editing with minor amendment at on 3rd August 2026